Exclusive: AI startup Chai lands GSK deal, its sixth pharma partner in nine months
4 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
"Exclusive: AI startup Chai lands GSK deal, its sixth pharma partner in nine months" is generating significant coverage in the Business category, with 4 articles from 4 distinct sources tracked by PULSE so far.
Outlets currently covering the story include Business Wire, FirstWord Pharma, Fierce Biotech and Endpoints News. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.
This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.
Generated by PULSE's extractive engine from coverage metadata only — no AI-written claims. Updated 39d ago.
Quick answers
Why is "Exclusive: AI startup Chai lands GSK deal, its sixth pharma partner in nine mont" trending?
Because 4 independent news sources published 4 articles about it in a short window — a coverage burst PULSE classifies as a trend.
How does PULSE measure this trend?
PULSE scores velocity from the rate of new articles weighted by source diversity, snapshotted hourly. The full method is public on our methodology page.
Is this trend still active?
The status badge on this page updates hourly: rising, peaking, cooling, or archived once coverage stops for 48 hours.
Coverage (5)
- Chai Discovery, GSK Announce Collaboration Following Wet-Lab Evaluation Contract Pharma · 40d ago
- Chai Discovery Announces Collaboration with GSK Following Successful Wet-Lab Evaluation Business Wire · 40d ago
- Chai adds GSK to its roster of pharma deals after positive lab tests FirstWord Pharma · 40d ago
- GSK drinks in Chai Discovery’s AI models after wet-lab validation Fierce Biotech · 40d ago
- Exclusive: AI startup Chai lands GSK deal, its sixth pharma partner in nine months Endpoints News · 40d ago
Topics
Related trends
Breakthrough: FDA Approves First Drug Offering a 'Functional Cure' For Chronic Hepatitis B
The US Food and Drug Administration and Health Canada have approved bepirovirsen, marketed as Hibsago, as the first functional cure for chronic hepatitis B.
Exclusive: Trump envoy's push to reopen Lithuanian ports to Belarus exposes rift in Washington
A push by a Trump envoy to reopen Lithuanian ports to Belarusian potash reveals internal splits in Washington.
New York Times Enters Exclusive Talks to Buy Letterboxd for $330 Million
The New York Times Company enters advanced talks to acquire the film platform Letterboxd.
Exclusive | Major Investors Are Skeptical Anthropic IPO Can Achieve $1.5 Trillion Valuation
Major investors express skepticism regarding Anthropic achieving a $1.5 trillion valuation for its public offering.
Exclusive
Nvidia-backed Genesis AI raised $500 million for its humanoid robot at a valuation of $3.5 billion.
Exclusive | Long-lost $3M Georgia O’Keeffe painting buried in NYC apartment closet for 40 years hits auction block
A long-lost Georgia O'Keeffe painting valued around $3 million has emerged from a New York City apartment closet after forty years.